Pharmacology

Action Mechanism of Action Reference
HYDROLYTIC ENZYME Chondroitin-6-sulfate hydrolytic enzyme FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Mucopolysaccharidosis IV 4 D009085 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
17.39
Respiratory, thoracic and mediastinal disorders
15.08
Gastrointestinal disorders
9.74
Infections and infestations
7.33
Nervous system disorders
7.18
Musculoskeletal and connective tissue disorders
6.62
Skin and subcutaneous tissue disorders
5.98
Cardiac disorders
5.29
Injury, poisoning and procedural complications
4.72
Vascular disorders
3.77
Investigations
3.38
Immune system disorders
2.94
Surgical and medical procedures
2.25
Psychiatric disorders
2.24

Cross References

Resources Reference
CAS NUMBER 9025-60-9
ChEMBL CHEMBL2108676
FDA SRS ODJ69JZG85
Guide to Pharmacology 7392